Editorial: Pulmonary hypertension associated with congenital heart disease

Editorial: Pulmonary hypertension associated with congenital heart disease

Bibliographic Details
Main Authors:	Siyi He, Hong Qian, Xingbo Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Pediatrics
Subjects:	pulmonary hypertension congenital heart disease pulmonary arterial smooth muscle cells inspiratory muscle training healthcare-associated infection omics
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2023.1217010/full

Similar Items

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
by: Maolin Zhao, et al.
Published: (2023-03-01)

Benefits of inspiratory muscle training in patients with pulmonary hypertension: A pilot study
by: Ioannis D. Laoutaris, et al.
Published: (2016-07-01)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
by: Antonio Lopes, et al.
Published: (2014-01-01)

Effectiveness and safety of inspiratory muscle training in patients with pulmonary hypertension: A systematic review and meta-analysis
by: Zeruxin Luo, et al.
Published: (2022-11-01)

Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt‐related pulmonary arterial hypertension
by: Jing‐jing Zhou, et al.
Published: (2022-10-01)

Respiratory and peripheral muscle involvement in patients with pulmonary arterial hypertension due to congenital heart diseases
by: Özge Keniş-Coşkun, et al.
Published: (2021-03-01)

Changing demographics of pulmonary arterial hypertension in congenital heart disease
by: B.J.M. Mulder
Published: (2010-12-01)

Echocardiography for the Assessment of Pulmonary Hypertension and Congenital Heart Disease in the Young
by: Katharina Meinel, et al.
Published: (2020-12-01)

Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling
by: Xiaowei Nie, et al.
Published: (2021-11-01)

Echinacoside prevents hypoxic pulmonary hypertension by regulating the pulmonary artery function
by: Xiangyun Gai, et al.
Published: (2020-12-01)

Evidence base for specific pulmonary vasodilators in adults with congenital heart disease
by: Anton A. Shmalts, et al.
Published: (2021-09-01)

The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
by: Haihua Qiu, et al.
Published: (2019-12-01)

Pulmonary hypertension associated with congenital heart disease; clinical decision scenario
by: Ali A. Alakhfash, et al.
Published: (2020-01-01)

Inspiratory muscle training in children and adolescents living with neuromuscular diseases: A pre-experimental study
by: Anri Human, et al.
Published: (2021-08-01)

Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension
by: Jingjing Zhou, et al.
Published: (2022-08-01)

Initial experiences with the treatment of pulmonary arterial hypertension in congenital heart disease in Slovenia
by: Katja Prokšelj, et al.
Published: (2013-04-01)

Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry
by: Harald Kaemmerer, et al.
Published: (2020-05-01)

Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells
by: Liu P, et al.
Published: (2021-04-01)

Functional outcomes associated with inspiratory muscle strength training in chronic obstructive pulmonary disease subjects: Narrative review
by: Veena Kiran Nambiar, et al.
Published: (2020-01-01)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
by: Yi Tong, et al.
Published: (2018-09-01)

Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review
by: Lidan Cui, et al.
Published: (2022-07-01)

Congenital Heart Disease with Pulmonary Hypertension; Surgery or Medical Treatment?
by: Ahmad Mirdamadi, et al.
Published: (2014-12-01)

RAS protein activator like 2 promotes the proliferation and migration of pulmonary artery smooth muscle cell through AKT/mammalian target of Rapamycin complex 1 pathway in pulmonary hypertension
by: Sheng Hu, et al.
Published: (2022-02-01)

Pulmonary arterial hypertension associated with congenital heart disease
by: Michele D'Alto, et al.
Published: (2012-12-01)

Transcription factors and potential therapeutic targets for pulmonary hypertension
by: Liu Yang, et al.
Published: (2023-03-01)

Effect of dexmedetomidine on pulmonary artery pressure in children with congenital heart disease and pulmonary hypertension
by: Muralidhar Kanchi, et al.
Published: (2020-01-01)

Pulmonary arterial hypertension in congenital heart disease: Current perspectives and future challenges
by: George Giannakoulas, MD, PhD, et al.
Published: (2016-07-01)

Segmental Pulmonary Hypertension in Children with Congenital Heart Disease
by: Bibhuti B. Das, et al.
Published: (2020-09-01)

Integrative Proteomic and Phosphoproteomic Analyses of Hypoxia-Treated Pulmonary Artery Smooth Muscle Cells
by: Ang Luo, et al.
Published: (2022-06-01)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
by: Li Gu, et al.
Published: (2020-03-01)

RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling
by: Sheng Hu, et al.
Published: (2023-12-01)

Where the congenital heart disease meets the pulmonary arterial hypertension, FLNA matters: a case report and literature review
by: Xiaoxian Deng, et al.
Published: (2020-11-01)

The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension
by: Yi-Chia Wu, et al.
Published: (2023-12-01)

Haemoptysis in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Insights on Pathophysiology, Diagnosis and Management
by: Amalia Baroutidou, et al.
Published: (2022-01-01)

The protective role of EP300 in monocrotaline-induced pulmonary hypertension
by: Lei Yang, et al.
Published: (2023-02-01)

Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation
by: Haihua Qiu, et al.
Published: (2021-03-01)

Hypoxia enhances interactions between Na+/H+ exchanger isoform 1 and actin filaments via ezrin in pulmonary vascular smooth muscle
by: Julie M. Lade, et al.
Published: (2023-02-01)

Effects of YM155 on the proliferation and apoptosis of pulmonary artery smooth muscle cells in a rat model of high pulmonary blood flow-induced pulmonary arterial hypertension
by: Bingbing Ye, et al.
Published: (2022-07-01)

Akt-Dependent Glycolysis-Driven Lipogenesis Supports Proliferation and Survival of Human Pulmonary Arterial Smooth Muscle Cells in Pulmonary Hypertension
by: Lifeng Jiang, et al.
Published: (2022-06-01)

IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis
by: Javier Milara, et al.
Published: (2022-11-01)